Atlas FDA

Alinity m CMV

FDA premarket approval P210022/S002 · decided 2022-11-28

Approval details

PMA number
P210022
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Alinity m CMV
Generic name
Cytomegalovirus (cmv) dna quantitative assay
Applicant
Abbott Molecular, Inc.
Date received
2022-11-03
Decision date
2022-11-28
Days to decision
25 days
Decision code
OK30
Product code
PAB
Advisory committee
Microbiology
Expedited review
No
Location
Des Plaines, IL
Statement
Implement a large-scale manufacturing process for the Alinity m CMV AMP Tray 1.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Alinity m HCV (K252102)Abbott Molecular, Inc.2025-09-25
Alinity m EBV (09N43-095) (K243489)Abbott Molecular, Inc.2025-07-28
Alinity m CMV (K243485)Abbott Molecular, Inc.2025-07-01
Alinity m BKV (K241921)Abbott Molecular, Inc.2025-03-24
Alinity m Resp-4-Plex (K241573)Abbott Molecular, Inc.2025-02-14
Alinity m HSV 1 & 2 / VZV (K233349)Abbott Molecular, Inc.2024-05-03
Alinity m STI Assay (K222379)Abbott Molecular, Inc.2023-03-03
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778)Abbott Molecular, Inc.2022-07-15